COVID-19 Infection, Reinfection, and Vaccine Effectiveness in Arizona Frontline and Essential Workers: Protocol for a Longitudinal Cohort Study

Journals

1. Ellingson K, Gerald J, Sun X, Hollister J, Lutrick K, Parker J, Rivers P, Beitel S, Baccam Z, Lamberte J, Grant L, Kim E, Bhattarai R, Komatsu K, Meece J, Kutty P, Thompson M, Burgess J. Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona. JAMA Health Forum 2021;2(10):e213318 View
2. Tyner H, Burgess J, Grant L, Gaglani M, Kuntz J, Naleway A, Thornburg N, Caban-Martinez A, Yoon S, Herring M, Beitel S, Blanton L, Nikolich-Zugich J, Thiese M, Pleasants J, Fowlkes A, Lutrick K, Dunnigan K, Yoo Y, Rose S, Groom H, Meece J, Wesley M, Schaefer-Solle N, Louzado-Feliciano P, Edwards L, Olsho L, Thompson M. Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection. Clinical Infectious Diseases 2022;75(1):e827 View
3. Fowlkes A, Gaglani M, Groover K, Thiese M, Tyner H, Ellingson K. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021. MMWR. Morbidity and Mortality Weekly Report 2021;70(34):1167 View
4. Hirschbühl K, Schaller T, Märkl B, Claus R, Sipos E, Rentschler L, Maccagno A, Grosser B, Kling E, Neidig M, Kröncke T, Spring O, Braun G, Bösmüller H, Seidl M, Esposito I, Pablik J, Hilsenbeck J, Boor P, Beer M, Dintner S, Wylezich C. High viral loads: what drives fatal cases of COVID-19 in vaccinees? – an autopsy study. Modern Pathology 2022;35(8):1013 View
5. Burns J, Rivers P, LeClair L, Jovel K, Rai R, Lowe A, Edwards L, Khan S, Mathenge C, Ferraris M, Kuntz J, Lamberte J, Hegmann K, Odean M, McLeland-Wieser H, Beitel S, Odame-Bamfo L, Schaefer Solle N, Mak J, Phillips A, Sokol B, Hollister J, Ochoa J, Grant L, Thiese M, Jacoby K, Lutrick K, Pubillones F, Yoo Y, Rentz Hunt D, Ellingson K, Berry M, Gerald J, Lopez J, Gerald L, Wesley M, Krupp K, Herring M, Madhivanan P, Caban-Martinez A, Tyner H, Meece J, Yoon S, Fowlkes A, Naleway A, Gwynn L, Burgess J, Thompson M, Olsho L, Gaglani M. Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study. JMIR Research Protocols 2022;11(7):e37929 View
6. Lutrick K, Fowlkes A, Rivers P, Herder K, Santibanez T, LeClair L, Groover K, Lamberte J, Grant L, Odame-Bamfo L, Ferraris M, Phillips A, Sokol B, Lowe A, Mathenge C, Pubillones F, Cottam B, McLeland-Wieser H, Jovel K, Ochoa J, Mckell J, Berry M, Khan S, Solle N, Rai R, Nakayima F, Newes-Adeyi G, Porter C, Baccam Z, Ellingson K, Burgess J, Gaglani M, Gwynn L, Caban-Martinez A, Yoon S. Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years — PROTECT Cohort, Four States, July 2021–May 2022. MMWR. Morbidity and Mortality Weekly Report 2022;71(35):1109 View
7. Veguilla V, Fowlkes A, Bissonnette A, Beitel S, Gaglani M, Porucznik C, Stockwell M, Tyner H, Naleway A, Yoon S, Caban-Martinez A, Wesley M, Duque J, Jeddy Z, Stanford J, Daugherty M, Dixon A, Burgess J, Odean M, Groom H, Phillips A, Schaefer-Solle N, Mistry P, Rolfes M, Thompson M, Dawood F, Meece J, Lainhart W. Detection and Stability of SARS-CoV-2 in Three Self-Collected Specimen Types: Flocked Midturbinate Swab (MTS) in Viral Transport Media, Foam MTS, and Saliva. Microbiology Spectrum 2022;10(3) View
8. Gabbasova N, Mamchik N, Yatsenko L, Mazina O, Knyazeva V. Monitoring of adverse events after immunization against a new coronavirus infection among young people. Epidemiology and Infectious Diseases 2022;26(3):104 View
9. Jergović M, Coplen C, Uhrlaub J, Beitel S, Burgess J, Lutrick K, Ellingson K, Watanabe M, Nikolich-Žugich J. Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved. The Journal of Immunology 2022;208(11):2461 View
10. Joseph G, Barnes J, Azziz-Baumgartner E, Arvay M, Fry A, Hall A, Kutty P, MacNeil A, Donald L, Reynolds S, Schrag S, Shang N, Slaughter R, Thornburg N, Verani J, Wang R, Hunt D, Sokol B, Bloodworth R, Douglas C, Gerber I, Hadden L, Harder J, McGarry N, Pickett S, Poe B, Shea M, Thacker J, Zheng P, Mistry P, Patlan K, Flores J, Duque J, Edwards L, Etolue J, LeClair L, Prather K, Smith M, Murthy K, Calhoun N, Hoffman E, Zayed M, Blais J, Ettlinger J, Settele N, Patel R, Priest E, Thomas J, Jatla M, Beeram M, Arroliga A, Prado Y, Sapp D, Lee M, Hornbrook M, Bialobok K, Alaspa J, Stafki D, Robinson M, Dolezilek J, Hoffman L, Connor T, Luzio C, Kendrick S, Cowling H, Healy O, Tovar G, Jarrah M, Nsengiyunva A, Slocum A, Steffen L, Smidt S, Coleman A, Deal C, Hanson H, Trejo I, Makar J, Grijalva S, Jovel K, Sharma P, Sun X, Nikolich-Žugich J, Gerald J, Fisher J, Krupp K, Gerald L, Littau S, Ramadan F, Woods E, Miiro F, Arani G, Tang N, Baccam N, Lowe A, Lobos A, Yingst A, Stea D, Mayhew N, Nava R, Porter C, Carmona A, strong A, Flangos A, Klinck C, Pikowski C, Hendrix C, Perez C, Morris C, Goebert E, Taylor G, Sowell J, Scott J, Mirabito J, Baker J, Naff K, Carson K, Obrien K, Earley K, Mevises K, Martinez M, Pena M, Hilyard R, Islam R, Perlman R, Murray S, Capell S, Bigler S, Thomas T, Butcher T, Graham T, Rojas C, Jones J, Astor B, Lee I, Desai M, Gomez V, Reyes R, Gallimore-Wilson D, Noriega R, Reyes A, Madan B, Cruz A, Carrera O, Suarez N, Feliciano P, Garibaldi J, Green A, Testoff A, Brown R, Schaefer C, Arteaga A, Bruner M, Dawson D, Eden E, Praggastis J, Stanford J, Mayer J, Stucki M, Campbell R, Tran K, Smith M, Black B, Pick C, Tallman M, Cox C, Wong D, Langston M, Fugal A, Tsang F, Wheeler M, Maughan G, Wilson M, Stinson P, Williams J, Smith T, Reed S, Mao J, allacher N, Chatard K, Vo J, Luong K, Jordin R, Stewart G, Bourdelle B, Powaukee T, Minoughan M, Whiting H, Souza A, Arlington I, Anderson L, Stubbs T, Park K, Jones T, Thompson M, Yoon S, Naleway A, Meece J, Fabrizio T, Caban-Martinez A, Burgess J, Gaglani M, Olsho L, Bateman A, Lundgren J, Grant L, Phillips A, Groom H, Stefanski E, Solle N, Ellingson K, Lutrick K, Dunnigan K, Wesley M, Guenther K, Hunt A, Mak J, Hegmann K, Kuntz J, Bissonnette A, Hollister J, Rose S, Morrill T, Respet K, Fowlkes A, Thiese M, Rivers P, Herring M, Odean M, Yoo Y, Brunner M, Bedrick E, Fleary D, Jones J, Romine J, Dickerson M, Khan S, Lamberte J, Beitel S, Webby R, Tyner H. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers. JAMA 2022;328(15):1523 View
11. Xiao Y, Lidsky P, Shirogane Y, Aviner R, Wu C, Li W, Zheng W, Talbot D, Catching A, Doitsh G, Su W, Gekko C, Nayak A, Ernst J, Brodsky L, Brodsky E, Rousseau E, Capponi S, Bianco S, Nakamura R, Jackson P, Frydman J, Andino R. A defective viral genome strategy elicits broad protective immunity against respiratory viruses. Cell 2021;184(25):6037 View
12. Lutrick K, Groom H, Fowlkes A, Groover K, Gaglani M, Rivers P, Naleway A, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese M, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine 2022;40(3):494 View
13. Caban-Martinez A, Gaglani M, Olsho L, Grant L, Schaefer-Solle N, Thompson M, Burgess J. COVID-19 Vaccination Perspectives and Illnesses Among Law Enforcement Officers, Firefighters, and Other First Responders in the US, January to September 2021. JAMA Network Open 2022;5(7):e2222640 View
14. Naleway A, Grant L, Caban‐Martinez A, Wesley M, Burgess J, Groover K, Gaglani M, Yoon S, Tyner H, Meece J, Kuntz J, Yoo Y, Schaefer‐Solle N, Olsho L, Gerald J, Rose S, Thiese M, Lundgren J, Groom H, Mak J, Louzado Feliciano P, Edwards L, Lutrick K, Dunnigan K, Phillips A, Lamberte J, Noriega R, Sokol B, Odean M, Ellingson K, Smith M, Hegmann K, Respet K, Dickerson M, Cruz A, Fleary D, Murthy K, Hunt A, Azziz‐Baumgartner E, Gallimore‐Wilson D, Harder J, Odame‐Bamfo L, Viergutz J, Arvay M, Jones J, Mistry P, Thompson M, Fowlkes A. Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 2021. Influenza and Other Respiratory Viruses 2022;16(3):585 View
15. Ellingson K, Hollister J, Porter C, Khan S, Feldstein L, Naleway A, Gaglani M, Caban-Martinez A, Tyner H, Lowe A, Olsho L, Meece J, Yoon S, Mak J, Kuntz J, Solle N, Respet K, Baccam Z, Wesley M, Thiese M, Yoo Y, Odean M, Miiro F, Pickett S, Phillips A, Grant L, Romine J, Herring M, Hegmann K, Lamberte J, Sokol B, Jovel K, Thompson M, Rivers P, Pilishvili T, Lutrick K, Burgess J, Midgley C, Fowlkes A. Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers. Emerging Infectious Diseases 2023;29(3):599 View
16. Herring M, Romine J, Wesley M, Ellingson K, Yoon S, Caban-Martinez A, Meece J, Gaglani M, Grant L, Olsho L, Tyner H, Naleway A, Khan S, Phillips A, Solle N, Rose S, Mak J, Fuller S, Hunt A, Kuntz J, Beitel S, Yoo Y, Zheng P, Arani G, Lamberte J, Edwards T, Thompson M, Sprissler R, Thornburg N, Lowe A, Pilishvili T, Uhrlaub J, Lutrick K, Burgess J, Fowlkes A. Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses. Clinical Infectious Diseases 2023;76(10):1822 View
17. Yoon S, Hegmann K, Thiese M, Burgess J, Ellingson K, Lutrick K, Olsho L, Edwards L, Sokol B, Caban-Martinez A, Schaefer-Solle N, Jones J, Tyner H, Hunt A, Respet K, Gaglani M, Dunnigan K, Rose S, Naleway A, Groom H, Kuntz J, Fowlkes A, Thompson M, Yoo Y. Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers. New England Journal of Medicine 2022;386(19):1855 View
18. Li Z, Liu F, Jefferson S, Horner L, Carney P, Johnson M, King J, Martin E, Zimmerman R, Wernli K, Gaglani M, Thompson M, Flannery B, Stevens J, Tumpey T, Levine M. Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza. Clinical Infectious Diseases 2022;75(Supplement_2):S271 View
19. Lyski Z, Porter C, Uhrlaub J, Ellingson K, Jeddy Z, Gwynn L, Rivers P, Sprissler R, Hegmann K, Coughlin M, Fowlkes A, Hollister J, LeClair L, Mak J, Beitel S, Fuller S, Grant L, Newes-Adeyi G, Yoo Y, Olsho L, Burgess J, Caban-Martinez A, Yoon S, Britton A, Gaglani M, Lutrick K. Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5–11 Years in a Multisite Prospective Cohort Study, September 2021–September 2022. Open Forum Infectious Diseases 2023;10(8) View
20. Monaco M, Spiteri G, Porru S. Coronavirus disease 2019 in the occupational settings. Current Opinion in Epidemiology and Public Health 2022;1(1):11 View
21. Rivers P, Jovel K, Ramadan F, Barnett J, Ellingson K, Burgess J, Lutrick K. Disease and social factors associated with healthcare utilization for the treatment of SARS-CoV-2 infections in a longitudinal cohort of essential workers in Arizona. BMC Health Services Research 2023;23(1) View
22. Hollister J, Caban-Martinez A, Ellingson K, Beitel S, Fowlkes A, Lutrick K, Tyner H, Naleway A, Yoon S, Gaglani M, Hunt D, Meece J, Mayo Lamberte J, Schaefer Solle N, Rose S, Dunnigan K, Khan S, Kuntz J, Fisher J, Coleman A, Britton A, Thiese M, Hegmann K, Pavuk M, Ramadan F, Fuller S, Nematollahi A, Sprissler R, Burgess J. Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies. Environmental Research 2023;239:117297 View
23. Rivers P, Porter C, LeClair L, Jeddy Z, Fowlkes A, Lamberte J, Herder K, Smith M, Rai R, Grant L, Hegmann K, Jovel K, Vaughan M, Mathenge C, Phillips A, Khan S, Britton A, Pilishvili T, Burgess J, Newes-Adeyi G, Gaglani M, Caban-Martinez A, Yoon S, Lutrick K. Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study. Vaccine 2024;42(7):1512 View
24. Chivu C, Crăciun M, Pițigoi D, Aramă V, Luminos M, Jugulete G, Constantin C, Apostolescu C, Streinu Cercel A. The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance Data. Vaccines 2024;12(2):182 View
25. Romine J, Li H, Coughlin M, Jones J, Britton A, Tyner H, Fuller S, Bloodworth R, Edwards L, Etolue J, Morrill T, Newes-Adeyi G, Olsho L, Gaglani M, Fowlkes A, Hollister J, Bedrick E, Uhrlaub J, Beitel S, Sprissler R, Lyski Z, Porter C, Rivers P, Lutrick K, Caban-Martinez A, Yoon S, Phillips A, Naleway A, Burgess J, Ellingson K. Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study. Clinical Infectious Diseases 2024;79(1):96 View
26. Porter C, Lyski Z, Uhrlaub J, Ellingson K, Jeddy Z, Gwynn L, Rivers P, Sprissler R, Hegmann K, Coughlin M, Fowlkes A, Hollister J, LeClair L, Mak J, Beitel S, Fuller S, Zheng P, Vaughan M, Rai R, Grant L, Newes-Adeyi G, Yoo Y, Olsho L, Burgess J, Caban-Martinez A, Yoon S, Britton A, Gaglani M, Phillips A, Thiese M, Hagen M, Jones J, Lutrick K. Evaluating Immunologic and Illness Outcomes of SARS-CoV-2 Infection in Vaccinated and Unvaccinated Children Aged ≥ 5 Years, in a Multisite Longitudinal Cohort. Diseases 2024;12(8):171 View
27. White E, Grant L, Mak J, Olsho L, Edwards L, Naleway A, Burgess J, Ellingson K, Tyner H, Gaglani M, Lutrick K, Caban-Martinez A, Newes-Adeyi G, Duque J, Yoon S, Phillips A, Thompson M, Britton A, Flannery B, Fowlkes A. Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study. Clinical Infectious Diseases 2024 View
28. Sood A, Jarrell W, Shore X, Sosa N, Parada A, Edwardson N, Yingling A, Amirkabirian T, Cheng Q, Hurwitz I, Cook L, Leng S, Myers O, Perkins D. Effectiveness of Frequent Point-of-Care Molecular COVID-19 Surveillance in a Rural Workplace: A Non-Randomized Controlled Clinical Trial Among Miners (Preprint). JMIR Public Health and Surveillance 2024 View